一个由过氧化激活的智能级联治疗前药物系统,用于输送 podophyllotoxin
Chengcheng Wu1, Haopai Wei1, Suntao Shi1
1State Key Laboratory of Applied Organic Chemistry and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, Gansu 730000, China. zhangbx@lzu.edu.cn.
Journal of materials chemistry. B
|January 6, 2025
概括
这项研究引入了一种新的治疗前药物,它选择性地使用过氧化 (H2O2) 作为触发剂来向癌细胞. 前药释放抗癌药物并发射光,用于实时监测,改善瘤治疗.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 选择性激活的前期药物对于最小化疾病治疗中的副作用至关重要.
- 级联自组装的视觉预制剂提供低背景干扰和现场光,用于目标激活.
- 过氧化 (H2O2) 是各种病理状况,包括癌症中的关键生物标志物.
研究的目的:
- 为增强癌症治疗设计和合成一种新型H2O2响应性治疗前药物 (CM-PPT).
- 允许同时释放抗癌药物和产生光,用于实时监测.
- 评估前药物在体外和体内针对个性化瘤治疗的疗效.
主要方法:
- 理性设计的治疗前药物 (CM-PPT) 结合 podophyllotoxin,一个光前体,和一个H2O2 敏感的酸盐.
- 在体外评估前药物激活,药物释放动力学和抗癌疗效.
- 在小鼠内腹膜内给药后对抗瘤活性进行体内评估.
主要成果:
- 合成的CM-PPT前药在体外显示出强大的抗癌疗效.
- 由H2O2触发的激活导致了活性抗癌分子和光片段的同时释放.
- 在体内研究显示出显著的抗瘤活性,验证了前药物的治疗潜力.
- 光强度与药物释放率相关,使药物输送的可视化成为可能.
结论:
- 开发的H2O2响应性原药为选择性癌症治疗学提供了一个有前途的平台.
- 这种方法有助于实时跟踪药物释放和可视化H2O2状态.
- 前药物设计具有个性化瘤治疗策略的潜力.
更多相关视频
相关概念视频
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
Peroxisomes
10.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
10.3K


